Suggestions
Frederique Welgryn
Global Vice President, Women's Health
Professional Background
Frederique Welgryn is a highly accomplished executive with over 20 years of extensive experience in the pharmaceutical and over-the-counter (OTC) healthcare sectors. With a profound passion for healthcare, particularly in the area of women’s health, Frederique has dedicated her career to enhancing access to vital sexual health solutions. Her professional journey reflects a relentless commitment to innovation, team empowerment, and business development. She possesses a wealth of experience in leading teams at prestigious companies, including Roche, AstraZeneca, and Sanofi, where she has consistently driven growth and achieved remarkable business outcomes.
Throughout her career, Frederique has played a pivotal role in shaping strategies that led to significant advancements in women's health. As a former Global Vice President at Perrigo Company plc and a member of the Executive Leadership Team at HRA Pharma, she spearheaded initiatives resulting in impressive revenue and profit growth—a staggering ten-fold increase through innovative Rx-to-OTC switches and strategic acquisitions. Her in-depth knowledge of the US market and her ability to navigate complex organizational structures have made her a sought-after leader in the industry.
Frederique’s authentic commitment to fostering an inclusive workplace culture is particularly noteworthy. She has a profound belief in promoting diversity within teams and ensuring that each team member is inspired to excel. Frederique has a remarkable history of developing and transforming organizations of varying sizes and cultures, demonstrating her adaptability and leadership acumen.
Education and Achievements
Frederique Welgryn’s educational foundations are robust, having studied pharmacy at Université Paris Cité where she acquired critical insights into pharmaceuticals that would later define her career. Furthermore, she holds a Master of Science (MS) in Management from HEC Paris, a prestigious institution known for its rigorous academic standards and focus on strategic management. This blend of technical and managerial skills has equipped Frederique with a well-rounded perspective, essential for leading innovation in the healthcare sector.
In her illustrious career, Frederique served in numerous pivotal roles that highlight her expertise in both strategic operations and innovation management. At HRA Pharma, where she held multiple leadership positions including Chief Strategic Operations and Innovation Officer, she was instrumental in directly reshaping the company’s strategic direction. As the Women's Health Global Therapeutic Domain Director, she led teams in pursuing new potential pathways for drug development, critical to advancing women’s health solutions.
Her earlier roles, including her time at AstraZeneca as the Oncology - Urology Business Unit Director and as the Oncology & Neurology Franchise Director at Sanofi Aventis France, further demonstrate her breadth of experience in pharmaceutical marketing and business operations.
Achievements
Frederique Welgryn's career is marked by several key achievements that underline her effectiveness as a leader in the pharmaceutical industry. One of her most notable successes is her leadership in generating substantial revenue increases while working with HRA Pharma. Through strategic innovation and operational excellence, Frederique helped pivot the company during transformative initiatives, fostering a culture of accountability and performance across the organization.
Under her guidance, teams and organizations have not only met but consistently surpassed their growth goals. Frederique’s strategic vision, combined with her operational expertise, has been a defining feature of her career. Her approach often involves fostering collaboration and encouraging input from diverse perspectives, ensuring that her teams are empowered to contribute their best ideas.
Frederique has also made significant contributions to the field of women's health, advocating for greater awareness and accessibility to sexual health products. This advocacy work, combined with her business acumen, positions her as a thought leader within the health industry. By leveraging her extensive background and experiences in both large corporations and innovative startups, Frederique continues to champion forward-thinking solutions that enhance healthcare access for women worldwide.
In conclusion, Frederique Welgryn's impressive career in the pharmaceutical sector is characterized by her dedication to innovation, effective team leadership, and a strong passion for women’s health. Combining her educational background with her extensive professional experience, Frederique remains a significant asset to any organization she joins, continuing to inspire others while striving to make impactful changes in the healthcare landscape.